Medicare Enrolled
Dr. Geraldo Saavedra, M.D.
Endocrinology · Whitehall, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saavedra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saavedra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saavedra
Dr. Geraldo Saavedra is an endocrinology specialist in Whitehall, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saavedra performed 594 Medicare services across 265 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saavedra received a total of $734,167 from 83 pharmaceutical and/or device companies across 3081 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saavedra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 46% volume in PA
$734,167 industry payments
Medicare Practice Summary
Medicare Utilization ↗594
Medicare services
Top 46% in PA for endocrinology
265
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~30 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
304 | $84 | $150 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
184 | $3 | $10 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
94 | $25 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $140 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$734,167
Total received (2018-2024)
Avg $104,881/year across 7 years
Top 1% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
3,081
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$694,771 (94.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$36,792 (5.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,604 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$64,416
2023
$74,529
2022
$101,066
2021
$92,491
2020
$117,606
2019
$166,606
2018
$117,452
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$35,847
Mannkind Corporation
$10,471
Novo Nordisk Inc
$5,975
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,928
Tandem Diabetes Care, Inc.
$2,095
Amgen Inc.
$936
AstraZeneca Pharmaceuticals LP
$863
Corcept Therapeutics
$695
Insulet Corporation
$551
Xeris Pharmaceuticals, Inc.
$331
ABBVIE INC.
$328
Bayer Healthcare Pharmaceuticals Inc.
$291
Novartis Pharmaceuticals Corporation
$246
Radius Health, Inc.
$231
Vifor Pharma, Inc.
$203
Abbott Laboratories
$167
Averitas Pharma Inc.
$153
Dexcom, Inc.
$153
Antares Pharma, Inc.
$135
OPKO Pharmaceuticals, LLC
$132
Alexion Pharmaceuticals, Inc.
$110
Esperion Therapeutics, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$72
Amphastar Pharmaceuticals, Inc.
$69
CeQur Corporation
$57
Madrigal Pharmaceuticals
$52
Kyowa Kirin, Inc.
$49
Medtronic, Inc.
$44
RECORDATI_RARE_DISEASES_INC.
$35
Tolmar, Inc.
$33
Verity Pharmaceuticals Inc.
$18
Astellas Pharma US Inc
$17
BETA BIONICS, INC.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 81.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$373,822
Novo Nordisk Inc
$130,591
Boehringer Ingelheim Pharmaceuticals, Inc.
$48,361
SANOFI-AVENTIS U.S. LLC
$41,447
AstraZeneca Pharmaceuticals LP
$33,835
Insulet Corporation
$27,898
Esperion Therapeutics, Inc.
$14,513
Mannkind Corporation
$11,322
MannKind Corporation
$8,412
CeQur Corporation
$5,969
Amgen Inc.
$4,871
AbbVie Inc.
$3,837
Medtronic, Inc.
$3,671
Tandem Diabetes Care, Inc.
$2,166
Corcept Therapeutics
$1,670
Janssen Pharmaceuticals, Inc
$1,662
Xeris Pharmaceuticals, Inc.
$1,555
OPKO Pharmaceuticals, LLC
$1,350
Abbott Laboratories
$1,196
Amarin Pharma Inc.
$1,153
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,146
Radius Health, Inc.
$919
ABBVIE INC.
$869
Bayer HealthCare Pharmaceuticals Inc.
$809
Allergan Inc.
$795
Merck Sharp & Dohme Corporation
$767
Senseonics, Incorporated
$739
Eli Lilly and Company
$721
Bayer Healthcare Pharmaceuticals Inc.
$637
Antares Pharma, Inc.
$509
Novartis Pharmaceuticals Corporation
$471
Vifor Pharma, Inc.
$467
Medtronic MiniMed, Inc.
$464
Shire North American Group Inc
$446
Dexcom, Inc.
$424
Sunovion Pharmaceuticals Inc.
$361
Synergy Pharmaceuticals Inc
$312
AbbVie, Inc.
$285
Valeritas, Inc.
$220
Ipsen Biopharmaceuticals, Inc
$208
PFIZER INC.
$196
Biohaven Pharmaceutical Holding Company Ltd.
$187
Averitas Pharma Inc.
$177
Alexion Pharmaceuticals, Inc.
$168
Becton, Dickinson and Company
$155
Kowa Pharmaceuticals America, Inc.
$151
Takeda Pharmaceuticals U.S.A., Inc.
$148
Biohaven Pharmaceuticals, Inc.
$140
Gilead Sciences, Inc.
$127
DEXCOM, INC.
$125
NESTLE HEALTHCARE NUTRITION INC.
$125
Kyowa Kirin, Inc.
$124
Amryt Pharma Holdings Ltd
$113
Avanir Pharmaceuticals, Inc.
$100
Supernus Pharmaceuticals, Inc.
$94
Tolmar, Inc.
$89
Zealand Pharma US, Inc.
$84
GlaxoSmithKline, LLC.
$83
Companion Medical, Inc.
$70
EISAI INC.
$70
Amphastar Pharmaceuticals, Inc.
$69
Merck Sharp & Dohme LLC
$67
Eisai Inc.
$56
Madrigal Pharmaceuticals
$52
Noden Pharma USA Inc
$45
Embecta Corp.
$44
Currax Pharmaceuticals LLC
$44
Acerus Pharmaceuticals Corporation
$43
Ascensia Diabetes Care Us Inc.
$38
RECORDATI_RARE_DISEASES_INC.
$35
Bigfoot Biomedical Inc
$33
Regeneron Healthcare Solutions, Inc.
$31
Horizon Therapeutics plc
$28
Medline Industries, Inc.
$27
Ultragenyx Pharmaceutical Inc.
$27
Ascendis Pharma Inc
$24
Verity Pharmaceuticals Inc.
$18
Nestle HealthCare Nutrition Inc.
$17
Astellas Pharma US Inc
$17
Amneal Pharmaceuticals LLC
$15
BETA BIONICS, INC.
$15
GENZYME CORPORATION
$12
VIVUS, Inc.
$11
Top 3 companies account for 75.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ASMANEX · Aimovig · Amitiza · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · BYSTOLIC · BYVALSON · Belviq · CINRYZE · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · Cryvista · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · ELIGARD · ENTRESTO · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · EVKEEZA · Enlite Sensor · Epclusa · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INVOKAMET · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · LYUMJEV · Livalo · MAVYRET · MINIMED 630G · MINIMED 770G · MINIMED 780G · MOTEGRITY · MOUNJARO · MOVANTIK · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · Motegrity · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · NUEDEXTA · NURTEC ODT · Natesto · Norditropin · OTREXUP · Omnipod · Otrexup · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · QULIPTA · QUTENZA · RAYALDEE · RECORLEV · RESMETIROM · RYBELSUS · Rayaldee · Repatha · Rybelsus · SEGLUROMET · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Sogroya · Somatuline Depot · Strensiq · Synthroid · TEKTURNA · TEPEZZA · THYROGEN · TLANDO · TOUJEO · TRADJENTA · TRIJARDY XR · TRULANCE · TRULICITY · TZIELD · Tlando · Tresiba · Trulance · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · UTIBRON · Uloric · V-GO · VIBERZI · VRAYLAR · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZEPBOUND · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in PA.
Geographic Context
Endocrinologists within 10 mi
31
Per 100K population
8.3
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
6.1 mi
6.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saavedra is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saavedra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Saavedra performed 304 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saavedra receive payments from pharmaceutical companies?
Yes. Dr. Saavedra received a total of $734,167 from 83 companies across 3,081 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saavedra's costs compare to other endocrinologists in Whitehall?
Dr. Saavedra's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saavedra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Whitehall
Browse endocrinologists in Whitehall ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in PA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in PA
Which PA endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology